Multiple System Atrophy (MSA): Clinical Trials

1 trial for Multiple System Atrophy (MSA), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Multiple System Atrophy (MSA): new trials by email Literature Review of Multiple System Atrophy (MSA) trials Research Report on Multiple System Atrophy (MSA)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA
SST001 - Multiple System Atrophy (MSA), Parkinson's Disease (PD)
Phase 1RecruitingSynusight Biotech (Shanghai) Co., Ltd.302026-06-152026-09-01

Narrower conditions

Multiple System Atrophy (1)  ·  Parkinson Disease (1)

Broader conditions

Autonomic Nervous System Diseases (1)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Movement Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Parkinsonian Disorders (1)  ·  Primary Dysautonomias (1)  ·  Synucleinopathies (1)

Sponsors

Synusight Biotech (Shanghai) Co., Ltd. (1)

Countries

China (1)